Novo Nordisk once-weekly insulin clears first phase 3 test
pharmaphorum
APRIL 29, 2022
For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying to change that. cases of hypoglycaemia per year with insulin icodec, versus 0.27 events for the once-daily drug. In absolute terms, there were 0.73
Let's personalize your content